首页> 外文期刊>BMC Nephrology >Outcomes of sustained low efficiency dialysis versus continuous renal replacement therapy in critically ill adults with acute kidney injury: a cohort study
【24h】

Outcomes of sustained low efficiency dialysis versus continuous renal replacement therapy in critically ill adults with acute kidney injury: a cohort study

机译:一项队列研究:在重症成人急性肾损伤中持续低效率透析与连续肾脏替代治疗的结果

获取原文
           

摘要

Background Sustained low efficiency dialysis (SLED) is increasingly used as a renal replacement modality in critically ill patients with acute kidney injury (AKI) and hemodynamic instability. SLED may reduce the hemodynamic perturbations of intermittent hemodialysis, while obviating the resource demands of CRRT. Although SLED is being increasingly used, few studies have evaluated its impact on clinical outcomes. Methods We conducted a cohort study comparing SLED (target 8?h/session, blood flow 200?mL/min, predominantly without anticoagulation) to CRRT in four ICUs at an academic medical centre. The primary outcome was mortality 30?days after RRT initiation, adjusted for demographics, comorbidity, baseline kidney function, and Sequential Organ Failure Assessment score. Secondary outcomes were persistent RRT dependence at 30?days and early clinical deterioration, defined as a rise in SOFA score or death 48?h after starting RRT. Results We identified 158 patients who initiated treatment with CRRT and 74 with SLED. Mortality at 30?days was 54?% and 61?% among SLED- and CRRT-treated patients, respectively [adjusted odds ratio (OR) 1.07, 95?% CI 0.56–2.03, as compared with CRRT]. Among SLED recipients, the risk of RRT dependence at 30?days (adjusted OR 1.36, 95?% CI 0.51–3.57) and early clinical deterioration (adjusted OR 0.73, 95?% CI 0.40–1.34) were not different as compared to patients who initiated CRRT. Conclusions Notwithstanding the limitations of this small non-randomized study, we found similar clinical outcomes for patients treated with SLED and CRRT. While we await the completion of a trial that will definitively assess the non-inferiority of SLED as compared to CRRT, SLED appears to be an acceptable alternative form of renal support in hemodynamically unstable patients with AKI.
机译:背景技术持续低效透析(SLED)在患有急性肾损伤(AKI)和血液动力学不稳定的重症患者中越来越多地被用作肾脏替代疗法。 SLED可以减少间歇性血液透析的血流动力学扰动,同时消除CRRT的资源需求。尽管越来越多地使用SLED,但很少有研究评估其对临床结果的影响。方法我们在一个学术医疗中心对四个ICU中的SRT(目标8?h /疗程,血流量200?mL / min,主要没有抗凝)与CRRT进行了一项队列研究。主要结果是RRT启动后30天的死亡率,并根据人口统计学,合并症,基线肾功能和器官功能衰竭评估评分进行了调整。次要结果是在30天时对RRT的持续依赖和早期临床恶化,这定义为开始RRT后48小时内SOFA评分升高或死亡。结果我们确定了158例开始CRRT治疗的患者和74例SLED治疗的患者。经SLED和CRRT治疗的患者在30天时的死亡率分别为54%和61%[与CRRT相比,校正后的优势比(OR)为1.07,95%CI为0.56-2.03]。在SLED接受者中,与患者相比,在30天时接受RRT依赖的风险(校正后的OR 1.36,95%CI为0.51–3.57)和早期临床恶化(校正后的OR为0.73,95%CI为0.40-1.34)。谁发起了CRRT。结论尽管这项小型非随机研究存在局限性,但我们发现接受SLED和CRRT治疗的患者的临床结局相似。尽管我们正在等待一项能够最终评估SLED与CRRT相比非劣效性的试验的完成,但SLED似乎是血液动力学不稳定的AKI患者可以接受的另一种肾脏支持形式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号